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Radiofrequency ablation (RFA) has become an important
therapeutic option for treatment of hepatocellular carci-
noma (HCC), the most common primary cancer.1 Liver ab-
scess (LA) is a potential complication associated with high
mortality rates after RFA, with an incidence ranging from
0.3% to 1.7% in the literature.2,3 Dysgonomonas capnocy-
tophagoides in LA is seldom reported, while Dysgonomonas
was recently introduced as a new genus containing three
species: Dysgonomonas mossi, Dysgonomonas gadei, and D.
capnocytophagoides (formerly Centers for Disease Control
and Prevention group DF-3).4 Whether D. capnocytopha-
goides is a frequent colonizer of the gastrointestinal tract
or a human pathogen remains controversial. Here, we
report a case of D. capnocytophagoides isolated from
blood- and liver-abscess cultures after RFA in a patient withConflicts of interest: The authors have no conflicts of interest
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A 73-year-old man presented with a history of HCC
(Barcelona clinic liver cancer, stage A), hepatitis C virus-
related liver cirrhosis (Child-Pugh score B), and type 2
diabetes mellitus. He had not previously received a biliary
stent or enterobiliary anastomosis surgery. He received RFA
over S3 for treatment of the HCC (tumor size: 3 cm) after
prophylactic parenteral cefazolin (1 gm stat) before the
procedure. However, abdominal distension occurred 2 days
later, followed by admission under suspicion of LAs. The
initial liver echogram showed a liquefaction and ill-defined
hypoechoic lesion of 2.6 cm over S8. Serial follow-up liver
echograms and echo-guided aspirations were performed
every other day after hospitalization, and cefoxitin was
prescribed empirically. D. capnocytophagoides was isolated
from the abscesses and blood on the 3rd day after admis-
sion. The Vitek GNI card (bio-Me´rieux, Hazelwood, MO,
USA) with the Vitek-2 system (bio-Me´rieux) identified the
isolates as D. capnocytophagoides. We also performed
conventional phenotypic tests for confirmation. Antimi-
crobial susceptibility was determined using a Vitek-2 card
(bio-Me´rieux) on a Vitek-2 system (bio-Me´rieux), with re-
sults showing susceptibility to tetracycline, trimethoprim-by Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
890 C.-H. Chen et al.sulphamethoxazole, and clindamycin. The patient received
parenteral ampicillin therapy (2000 mg every 6 h) for 28
days, followed by oral amoxicillin (750 mg every 8 h). He
also received 2 months of antibiotic therapy after this
bacteremia episode and remains on HCC therapy.
To our knowledge, this is the first case report of D.
capnocytophagoides bacteremia due to LAs after RFA in a
patient with HCC. We carried out systematic searches of
the literature and summarized our review in Table S1. Sig-
nificant risk factors for LA development after RFA are the
presence of biliary abnormalities or manipulation or the risk
for ascending biliary infection.2,3 Antibiotic prophylaxis is
controversial in all HCC patients after RFA, but in high-risk
cases, it is recommended.2,3,5 In this patient, we prescribed
antibiotic prophylaxis before RFA in order to reduce po-
tential complication after procedure, and he still happened
to D. capnocytophagoides bacteremia. It needs further
study to determine which kind of prophylactic antibiotic for
reducing D. capnocytophagoides incidence after RFA.
In conclusion, we described a case of D. capnocytopha-
goides bacteremia due to LAs after RFA in a patient with
HCC. This case supports the assumption that D. capnocy-
tophagoides is an opportunistic pathogen in immunocom-
promised hosts. Physicians should, therefore, be aware of
this possibility during patient clinical follow-ups, especially
in patients with risk factors for infection.
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